JULIA FREUND: Open Payments
NPI 1780313288 · FLORISSANT, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$709 in 37 payments from 12 companies in 2025. Trend: 2023 $393 · 2024 $798 · 2025 $709
Food & beverage: $709
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $154 |
| Amgen Inc. | 9 | $136 |
| ABBVIE INC. | 6 | $128 |
| Lilly USA, LLC | 3 | $60 |
| Novo Nordisk Inc | 3 | $55 |
| PFIZER INC. | 2 | $38 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| Novartis Pharmaceuticals Corporation | 2 | $29 |
| Exact Sciences Corporation | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $20 |
Products named: AIRSUPRA, EVENITY, UBRELVY, QULIPTA, JARDIANCE, OTEZLA, Wegovy, LEQVIO.
Industry payments across MO — which companies pay providers there.
